International Congress on Cancer Metastasis

cancermetastasis.org

 

Tumor Mutational Burden as a Biomarker in the Evolving Oncology Landscape: TMB is Associated w/ Clinical Response to Single Agent Pembrolizumab

0 views
November 28, 2019
Comments 0
Login to view comments. Click here to Login